Maximal Bruce Protocol With the Use of Regadenoson For Myocardial Perfusion Stress Testing
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
It is been known for at least 20 years that the hemodynamic data, the amount of exercise
performed as well as symptoms on the treadmill, has significant value to the perfusion stress
testing. When a pharmacologic stress test is performed (and adenosine stress test over 4-6
minutes), this hemodynamic data is lost. Because of this loss of valuable data, it is felt
that there is also a loss of significant prognostic data as well. With the advent and FDA
release of Regadenoson in a rapid injection form (over 10 seconds), it is thought that the
combination of both exercise stress testing and pharmacologic testing in subjects that do not
achieve 85% in a maximal predicted heart rate may be a viable stress testing option.
The purpose of this study is to look at using the drug, regadenoson, with exercise stress
testing; and the side effect symptoms that may be experienced by individual subjects using
this combination.
Phase:
N/A
Details
Lead Sponsor:
University of Maryland University of Maryland, Baltimore